Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aileron Therapeutics Inc (ALRN) has provided an update.
Aileron Therapeutics, Inc. announced that Dr. Manuel C. Alves-Aivado stepped down as CEO on March 11, 2024, but will continue to serve on the Board. His departure was amicable, with no disagreements cited. Dr. Brian Windsor was appointed as the new CEO and also joined the Board, bringing extensive experience from previous leadership roles in biopharmaceutical companies. Dr. Aivado will receive severance benefits, including extended salary and medical insurance coverage, as per his 2018 agreement with the company.
For detailed information about ALRN stock, go to TipRanks’ Stock Analysis page.